94 related articles for article (PubMed ID: 23231949)
1. IGKC and prognosis in breast cancer--response to Schmidt.
Whiteside TL; Ferrone S
Clin Cancer Res; 2013 Jan; 19(1):305. PubMed ID: 23231949
[No Abstract] [Full Text] [Related]
2. IGKC and prognosis in breast cancer.
Schmidt M; Micke P; Hengstler JG
Clin Cancer Res; 2013 Jan; 19(1):304. PubMed ID: 23231948
[No Abstract] [Full Text] [Related]
3. For breast cancer prognosis, immunoglobulin kappa chain surfaces to the top.
Whiteside TL; Ferrone S
Clin Cancer Res; 2012 May; 18(9):2417-9. PubMed ID: 22442060
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.
Schmidt M; Hellwig B; Hammad S; Othman A; Lohr M; Chen Z; Boehm D; Gebhard S; Petry I; Lebrecht A; Cadenas C; Marchan R; Stewart JD; Solbach C; Holmberg L; Edlund K; Kultima HG; Rody A; Berglund A; Lambe M; Isaksson A; Botling J; Karn T; Müller V; Gerhold-Ay A; Cotarelo C; Sebastian M; Kronenwett R; Bojar H; Lehr HA; Sahin U; Koelbl H; Gehrmann M; Micke P; Rahnenführer J; Hengstler JG
Clin Cancer Res; 2012 May; 18(9):2695-703. PubMed ID: 22351685
[TBL] [Abstract][Full Text] [Related]
5. Identification of reference genes for circulating microRNA analysis in colorectal cancer.
Niu Y; Wu Y; Huang J; Li Q; Kang K; Qu J; Li F; Gou D
Sci Rep; 2016 Oct; 6():35611. PubMed ID: 27759076
[TBL] [Abstract][Full Text] [Related]
6. Enhancing detection of circulating tumor cells with activating KRAS oncogene in patients with colorectal cancer by weighted chemiluminescent membrane array method.
Yang MJ; Chiu HH; Wang HM; Yen LC; Tsao DA; Hsiao CP; Chen YF; Wang JY; Lin SR
Ann Surg Oncol; 2010 Feb; 17(2):624-33. PubMed ID: 19937133
[TBL] [Abstract][Full Text] [Related]
7. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
8. Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy.
Hellwig B; Madjar K; Edlund K; Marchan R; Cadenas C; Heimes AS; Almstedt K; Lebrecht A; Sicking I; Battista MJ; Micke P; Schmidt M; Hengstler JG; Rahnenführer J
PLoS One; 2016; 11(12):e0167585. PubMed ID: 27926932
[TBL] [Abstract][Full Text] [Related]
9. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
[TBL] [Abstract][Full Text] [Related]
11. Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer.
de Boer E; Crane LM; van Oosten M; van der Vegt B; van der Sluis T; Kooijman P; Low PS; van der Zee AG; Arts HJ; van Dam GM; Bart J
PLoS One; 2015; 10(8):e0135012. PubMed ID: 26248049
[TBL] [Abstract][Full Text] [Related]
12. Expression of aphidicolin-induced fragile sites and their relationship between genetic susceptibility in breast cancer, ovarian cancer, and non-small-cell lung cancer patients.
Dhillon VS; Husain SA; Ray GN
Teratog Carcinog Mutagen; 2003; Suppl 1():35-45. PubMed ID: 12616595
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase-I PS506 as a Dual Function Cancer Biomarker.
Zhao M; Gjerset RA
PLoS One; 2015; 10(8):e0134929. PubMed ID: 26248194
[TBL] [Abstract][Full Text] [Related]
14. Validation of a reverse transcription-polymerase chain reaction-based five-gene signature in non-small cell lung cancer.
Ruco L; Scarpino S; Natoli G
J Thorac Oncol; 2009 May; 4(5):670. PubMed ID: 19395916
[No Abstract] [Full Text] [Related]
15. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
Uvirova M; Simova J; Kubova B; Dvorackova N; Tomaskova H; Sedivcova M; Dite P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):466-71. PubMed ID: 26077004
[TBL] [Abstract][Full Text] [Related]
16. Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers.
Forgacs E; Wren JD; Kamibayashi C; Kondo M; Xu XL; Markowitz S; Tomlinson GE; Muller CY; Gazdar AF; Garner HR; Minna JD
Oncogene; 2001 Feb; 20(8):1005-9. PubMed ID: 11314036
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Multigene Testing: Catching the Train That's Left the Station.
Swisher EM
JAMA Oncol; 2015 Oct; 1(7):951-2. PubMed ID: 26270409
[No Abstract] [Full Text] [Related]
18. Reclassifying colorectal cancer subtypes.
Burki TK
Lancet Oncol; 2015 Dec; 16(16):e591. PubMed ID: 26511645
[No Abstract] [Full Text] [Related]
19. Cancer in the family. Part 2.
Kefford R; Tucker K; Friedlander M; Kirk J
Aust Fam Physician; 1998; 27(1-2):40-4. PubMed ID: 9503704
[TBL] [Abstract][Full Text] [Related]
20. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
